Evidence map›Paper›PMID 24051159›Full record

ArticleVaccine2014

DNA-based adaptive immunity protect host from infection-associated periodontal bone resorption via recognition of Porphyromonas gingivalis virulence component.

Xiaozhe Han, Karen B LaRosa, Toshihisa Kawai, Martin A Taubman

Open access · greenAbstract read
In one paragraph

Article in Vaccine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Design of a Novel Multi Epitope-Based Vaccine for Pandemic Coronavirus Disease (COVID-19) by Vaccinomics and Probable Prevention Strategy against Avenging Zoonotics.European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences · 2020
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Xiaozhe HanThe Forsyth Institute, Department of Immunology and Infectious Diseases, 245 First Street, Cambridge, MA, United States. Electronic address: xhan@forsyth.org.
Karen B LaRosaThe Forsyth Institute, Department of Immunology and Infectious Diseases, 245 First Street, Cambridge, MA, United States.
Toshihisa KawaiThe Forsyth Institute, Department of Immunology and Infectious Diseases, 245 First Street, Cambridge, MA, United States.
Martin A TaubmanThe Forsyth Institute, Department of Immunology and Infectious Diseases, 245 First Street, Cambridge, MA, United States.
Forsyth County Schools · US

Funding

P. gingivalis as a keystone pathogenR01DE015254 · NIDCR · UNIVERSITY OF PENNSYLVANIA · PI HAJISHENGALLIS, GEORGIOS · 2004 to 2018
$4.6M
REGULATORY CELLS IN EXPERIMENTAL PERIODONTAL DISEASER01DE003420 · NIDCR · FORSYTH INSTITUTE · PI KAWAI, TOSHIHISA · 1985 to 2012
$4.3M
SYNTHETIC PEPTIDE VACCINES FOR DENTAL CARIESR01DE004733 · NIDCR · FORSYTH INSTITUTE · PI TAUBMAN, MARTIN A · 1985 to 2005
$3.0M
Passive Immunotherapy for Pediatric Mutans Streptococcal InfectionsR56DE004733 · NIDCR · ADA FORSYTH INSTITUTE, INC. · PI TAUBMAN, MARTIN A · 2007 to 2009
$2.1M
Regulation of B-Cell Apoptosis by TLR Signaling in Periodontal DiseaseR21DE021837 · NIDCR · ADA FORSYTH INSTITUTE, INC. · PI HAN, XIAOZHE · 2011 to 2012
$543k
Tolerance to Oral Bacteria in Periodontal InflammationK22DE014551 · NIDCR · FORSYTH INSTITUTE · PI KAWAI, TOSHIHISA · 2002 to 2005
$541k
REGULATORY CELLS IN EXPERIMENTAL PERIODONTAL DISEASER37DE003420 · NIDCR · FORSYTH INSTITUTE · PI TAUBMAN, MARTIN A · 1990 to 1999
–
NIDCR NIH HHS DE-014551NIDCR NIH HHS DE-015254NIDCR NIH HHS DE-03420NIDCR NIH HHS DE-04733NIDCR NIH HHS K22 DE014551NIDCR NIH HHS R01 DE003420NIDCR NIH HHS R01 DE004733NIDCR NIH HHS R01 DE015254NIDCR NIH HHS R21 DE021837NIDCR NIH HHS R37 DE003420NIDCR NIH HHS R56 DE004733
6 · The paper itself

Abstract

backgroundPorphyromonas gingivalis (Pg) is one of a constellation of oral organisms associated with human chronic periodontitis. While adaptive immunity to periodontal pathogen proteins has been investigated and is an important component of periodontal bone resorption, the effect of periodontal pathogen DNA in eliciting systemic and mucosal antibody and modulating immune responses has not been investigated.

methodsRowett rats were locally injected with whole genomic Pg DNA in alum. Escherichia coli (Ec) genomic DNA, Fusobacterium nucleatum (Fn) genomic DNA, and saline/alum injected rats served as controls. After various time points, serum IgG and salivary IgA antibody to Ec, Fn or Pg were detected by ELISA. Serum and salivary antibody reactions with Pg surface antigens were determined by Western blot analyses and the specific antigen was identified by mass spectrometry. Effects of genomic DNA immunization on Pg bacterial colonization and experimental periodontal bone resorption were also evaluated.

resultsSera from Pg DNA, Ec DNA and Fn DNA-injected rats did not react with Ec or Fn bacteria. Serum IgG antibody levels to Pg and Pg surface extracts were significantly higher in animals immunized with Pg DNA as compared to the control groups. Rats injected with Pg DNA demonstrated a strong serum IgG and salivary IgA antibody reaction solely to Pg fimbrillin (41kDa), the major protein component of Pg fimbriae. In the Pg DNA-immunized group, the numbers of Pg bacteria in oral cavity and the extent of periodontal bone resorption were significantly reduced after Pg infection.

conclusionsThis study suggests that infected hosts may select specific genes from whole genomic DNA of the periodontal pathogen for transcription and presentation. The results indicate that the unique gene selected can initiate a host protective immune response to the parent bacterium.

Indexed as

Adaptive ImmunityAlveolar Bone LossAnimalsAntibody FormationBacterial VaccinesBacteroidaceae InfectionsDNA, BacterialFemaleFimbriae, BacterialFimbriae ProteinsImmunoglobulin AImmunoglobulin GMouthPeriodontitisPorphyromonas gingivalisRatsBacterial VaccinesDNA, BacterialFimbriae ProteinsfimbrillinImmunoglobulin AImmunoglobulin GVaccines, DNAantigen presenting cellsAPCsBacterial genomic DNABone resorptionEcELISAenzyme-linked immunosorbent assayEscherichia coliFnFusobacterium nucleatumImmune responselipopolysaccharideLPSmass spectrometryMSPeriodontal diseasePgPorphyromonas gingivalisVaccine

Identifiers

PMID24051159
PMCPMC3872268
OpenAlexW2080434457

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.